Kemps-Polanco Reshema (CIK 2009357) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-11). Recent activity: Buy CRL (1,438 shares), Buy CRL (535 shares), Buy CRL (946 shares), Buy CRL (630 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | Buy | 1,438 | $255,418 |
| 2026-05-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | Buy | 535 | $95,027 |
| 2025-05-23 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | Buy | 946 | $127,691 |
| 2025-05-23 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | Buy | 630 | $85,037 |
Source: SEC Form 4 filings · as of 2026-05-11